Tibo Duran

AI
h-index7
3papers
3citations
Novelty53%
AI Score45

3 Papers

3.3QMAug 15, 2024Code
Exploring Latent Space for Generating Peptide Analogs Using Protein Language Models

Po-Yu Liang, Xueting Huang, Tibo Duran et al.

Generating peptides with desired properties is crucial for drug discovery and biotechnology. Traditional sequence-based and structure-based methods often require extensive datasets, which limits their effectiveness. In this study, we proposed a novel method that utilized autoencoder shaped models to explore the protein embedding space, and generate novel peptide analogs by leveraging protein language models. The proposed method requires only a single sequence of interest, avoiding the need for large datasets. Our results show significant improvements over baseline models in similarity indicators of peptide structures, descriptors and bioactivities. The proposed method validated through Molecular Dynamics simulations on TIGIT inhibitors, demonstrates that our method produces peptide analogs with similar yet distinct properties, highlighting its potential to enhance peptide screening processes.

2.4AIJan 19Code
PepEDiff: Zero-Shot Peptide Binder Design via Protein Embedding Diffusion

Po-Yu Liang, Tobo Duran, Jun Bai

We present PepEDiff, a novel peptide binder generator that designs binding sequences given a target receptor protein sequence and its pocket residues. Peptide binder generation is critical in therapeutic and biochemical applications, yet many existing methods rely heavily on intermediate structure prediction, adding complexity and limiting sequence diversity. Our approach departs from this paradigm by generating binder sequences directly in a continuous latent space derived from a pretrained protein embedding model, without relying on predicted structures, thereby improving structural and sequence diversity. To encourage the model to capture binding-relevant features rather than memorizing known sequences, we perform latent-space exploration and diffusion-based sampling, enabling the generation of peptides beyond the limited distribution of known binders. This zero-shot generative strategy leverages the global protein embedding manifold as a semantic prior, allowing the model to propose novel peptide sequences in previously unseen regions of the protein space. We evaluate PepEDiff on TIGIT, a challenging target with a large, flat protein-protein interaction interface that lacks a druggable pocket. Despite its simplicity, our method outperforms state-of-the-art approaches across benchmark tests and in the TIGIT case study, demonstrating its potential as a general, structure-free framework for zero-shot peptide binder design. The code for this research is available at GitHub: https://github.com/LabJunBMI/PepEDiff-An-Peptide-binder-Embedding-Diffusion-Model

2.6LGSep 16, 2024Code
Uncovering the Mechanism of Hepatotoxiciy of PFAS Targeting L-FABP Using GCN and Computational Modeling

Lucas Jividen, Tibo Duran, Xi-Zhi Niu et al.

Per- and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants with known toxicity and bioaccumulation issues. Their widespread industrial use and resistance to degradation have led to global environmental contamination and significant health concerns. While a minority of PFAS have been extensively studied, the toxicity of many PFAS remains poorly understood due to limited direct toxicological data. This study advances the predictive modeling of PFAS toxicity by combining semi-supervised graph convolutional networks (GCNs) with molecular descriptors and fingerprints. We propose a novel approach to enhance the prediction of PFAS binding affinities by isolating molecular fingerprints to construct graphs where then descriptors are set as the node features. This approach specifically captures the structural, physicochemical, and topological features of PFAS without overfitting due to an abundance of features. Unsupervised clustering then identifies representative compounds for detailed binding studies. Our results provide a more accurate ability to estimate PFAS hepatotoxicity to provide guidance in chemical discovery of new PFAS and the development of new safety regulations.